Inactive Instrument

Company DigiPath, Inc. Other OTC

Equities

DIGP

US2538252022

Fishing & Farming

Business Summary

Hypha Labs, Inc., formerly Digipath, Inc., has developed technology that cultivates the mycelium root structures of psilocybin mushrooms and other functional mushroom's mycelium into a natural product. This product has an exact, consistent potency containing all the natural compounds found in these fungi. Typically, it takes six-eight weeks to fully grow mushrooms, and using its technology, the production of the active ingredient is only seven-10 days. This natural product solves the dosing issue created by having to use whole mushrooms. The product is tasteless and gentler on the stomach and can be used sublingually for fast-acting results. The product allows the consumer to produce measurable active ingredients at home for mental and physical benefits. It provides Psilocybin Mushrooms, Button Mushrooms, Shiitake Mushrooms, Maitake Mushrooms, Reishi Mushrooms, Lion's Mane Mushrooms, Oyster Mushrooms, Oyster Mushrooms and Crimini Mushrooms.

Managers

Managers TitleAgeSince
Chief Executive Officer 76 21-06-30
Director/Board Member 68 19-09-24

Members of the board

Members of the board TitleAgeSince
Chief Executive Officer 76 21-06-30
Director/Board Member 68 19-09-24

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 0 333,600 0 0 79.76 %
Stock B 1 87,096,820 70,306,329 ( 80.72 %) 0
Stock C 0 1,047,942 0 0

Shareholders

NameEquities%Valuation
6,216,667 7.138 % 136 767 $
3,500,000 4.019 % 77 000 $
3,290,000 3.777 % 72 380 $
2,958,824 3.397 % 65 094 $
825,000 0.9472 % 18 150 $
NameEquities%Valuation
400,000 9.825 % 8 800 $

Company contact information

DigiPath, Inc.

5940 South Rainbow Boulevard

89118, Las Vegas

+

http://hyphalabs.com
address DigiPath, Inc.(DIGP)